Literature DB >> 26773160

Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS.

Mikaël Croyal1, Fanta Fall1, Véronique Ferchaud-Roucher1, Maud Chétiveaux2, Yassine Zaïr2, Khadija Ouguerram1, Michel Krempf3, Estelle Nobécourt4.   

Abstract

A multiplexed assay was developed by MS to analyze, in a single run, six major human Apos involved in lipoprotein metabolism: ApoA-I, ApoA-II, ApoB100, ApoC-II, ApoC-III, and ApoE. This method was validated in vivo in six subjects who received a 14 h constant infusion of [5,5,5-(2)H3]L-leucine at 10 μM/kg/h. Plasma lipoprotein fractions were isolated from collected blood samples and were digested with trypsin. Proteotypic peptides were subsequently analyzed by LC/MS/MS. Enrichment measurement data were compared with those obtained by the standard method using GC/MS. The required time to obtain the LC/MS/MS data was less than that needed for GC/MS. The enrichments from both methods were correlated for ApoA-I (r = 0.994; P < 0.0001) and ApoB100 (r = 0.999; P < 0.0001), and the Bland-Altman plot confirmed the similarity of the two methods. Intra- and inter-assay variability calculated for the six Apos of interest did not exceed 10.7 and 12.5%, respectively, and kinetic parameters were similar and/or in agreement with previously reported data. Therefore, LC/MS/MS can be considered as a useful tool for human Apo kinetic studies using stable isotopes.
Copyright © 2016 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  lipoproteins/kinetics; lipoproteins/metabolism; liquid chromatography-tandem mass spectrometry; multiplexed assay; nutrition protein; stable isotope

Mesh:

Substances:

Year:  2016        PMID: 26773160      PMCID: PMC4766983          DOI: 10.1194/jlr.D064618

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  29 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

2.  Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry.

Authors:  Michael E Lassman; Theresa M McLaughlin; Haihong Zhou; Yi Pan; Santica M Marcovina; Omar Laterza; Thomas P Roddy
Journal:  Rapid Commun Mass Spectrom       Date:  2014-05-30       Impact factor: 2.419

3.  Measurement of fractional synthetic rates of multiple protein analytes by triple quadrupole mass spectrometry.

Authors:  Anita Y H Lee; Nathan A Yates; Marina Ichetovkin; Ekaterina Deyanova; Katie Southwick; Timothy S Fisher; Weixun Wang; James Loderstedt; Nykia Walker; Haihong Zhou; Xuemei Zhao; Carl P Sparrow; Brian K Hubbard; Daniel J Rader; Ayesha Sitlani; John S Millar; Ronald C Hendrickson
Journal:  Clin Chem       Date:  2012-01-16       Impact factor: 8.327

4.  Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.

Authors:  K Bach-Ngohou; K Ouguerram; R Frénais; P Maugère; B Ripolles-Piquer; Y Zaïr; M Krempf; J M Bard
Journal:  J Pharmacol Exp Ther       Date:  2005-07-13       Impact factor: 4.030

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 6.  Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data.

Authors:  D M Foster; P H Barrett; G Toffolo; W F Beltz; C Cobelli
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

7.  Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics.

Authors:  A H Lichtenstein; J S Cohn; D L Hachey; J S Millar; J M Ordovas; E J Schaefer
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

Review 8.  Lipidomics as a principal tool for advancing biomedical research.

Authors:  Sin Man Lam; Guanghou Shui
Journal:  J Genet Genomics       Date:  2013-07-12       Impact factor: 4.275

Review 9.  Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.

Authors:  P Hugh R Barrett; Gerald F Watts
Journal:  Curr Opin Lipidol       Date:  2003-02       Impact factor: 4.776

10.  Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS/MS.

Authors:  Uta Ceglarek; Julia Dittrich; Susen Becker; Frank Baumann; Linda Kortz; Joachim Thiery
Journal:  Proteomics Clin Appl       Date:  2013-10-31       Impact factor: 3.494

View more
  8 in total

Review 1.  Unbiased and targeted mass spectrometry for the HDL proteome.

Authors:  Sasha A Singh; Masanori Aikawa
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

2.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

3.  Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins.

Authors:  Lang Ho Lee; Allison B Andraski; Brett Pieper; Hideyuki Higashi; Frank M Sacks; Masanori Aikawa; Sasha A Singh
Journal:  Proteomics       Date:  2017-01       Impact factor: 3.984

4.  Characterization of lipoproteins and associated lipidome in very preterm infants: a pilot study.

Authors:  Alice Küster; Mikael Croyal; Thomas Moyon; Dominique Darmaun; Khadija Ouguerram; Véronique Ferchaud-Roucher
Journal:  Pediatr Res       Date:  2022-06-23       Impact factor: 3.756

5.  Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study.

Authors:  Valentin Blanchard; Stéphane Ramin-Mangata; Stéphanie Billon-Crossouard; Audrey Aguesse; Manon Durand; Kevin Chemello; Brice Nativel; Laurent Flet; Maud Chétiveaux; David Jacobi; Jean-Marie Bard; Khadija Ouguerram; Gilles Lambert; Michel Krempf; Mikaël Croyal
Journal:  J Lipid Res       Date:  2018-03-14       Impact factor: 5.922

6.  IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.

Authors:  Maud Charpentier; Mikael Croyal; Delphine Carbonnelle; Agnès Fortun; Laetitia Florenceau; Catherine Rabu; Michel Krempf; Nathalie Labarrière; François Lang
Journal:  Oncotarget       Date:  2016-09-13

7.  Characterization of Affitin proteolytic digestion in biorelevant media and improvement of their stabilities via protein engineering.

Authors:  Aurélie Loussouarn; Ghislaine Béhar; Frédéric Pecorari; Mikael Croyal; Axelle Renodon-Cornière
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

8.  Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis.

Authors:  Brynne E Whitacre; Philip Howles; Scott Street; Jamie Morris; Debi Swertfeger; W Sean Davidson
Journal:  J Lipid Res       Date:  2021-12-01       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.